# H2AC16

## Overview
H2AC16 is a gene that encodes the H2A clustered histone 16 protein, a variant of the histone H2A family. Histones are fundamental components of chromatin, playing a critical role in the organization and regulation of DNA within the nucleus. The H2A clustered histone 16 protein is involved in chromatin dynamics, influencing gene expression and DNA repair processes. It is particularly significant in the context of proliferative diabetic retinopathy and various cancers, where it has been identified as a driver gene. The protein's interactions with other histone variants suggest its involvement in oxidative stress-related pathways and chromatin remodeling, which are crucial for maintaining genomic stability and regulating cellular responses to environmental changes (Ostroverkhova2023Leveraging; Wang2024Unveiling).

## Clinical Significance
Mutations and alterations in the expression of the H2AC16 gene have been implicated in various cancers. H2AC16 has been identified as a driver gene in squamous cell carcinoma and adenocarcinoma, suggesting its significant role in the oncogenesis of these cancers (Ostroverkhova2023Leveraging). The mutation rate of H2AC16 is positively correlated with replication time and negatively with expression level, indicating that these factors may influence its mutation rate (Ostroverkhova2023Leveraging). 

In addition to its role in cancer, downregulation of H2AC16 has been linked to increased genomic instability in certain cancer types, such as giant cell tumor of bone stromal cells, suggesting that alterations in its expression may contribute to genomic instability and potentially influence cancer progression (Ragusa2023Contribution). The presence of histone mutations, including those in H2AC16, is associated with defective DNA Polymerase Epsilon mutations, which may further link these mutations to cancer development (Ostroverkhova2023Leveraging).

Overall, the clinical significance of H2AC16 mutations and expression alterations highlights its potential as a target for further research and therapeutic intervention in cancer treatment.

## Interactions
H2AC16, a variant of the histone H2A protein, is involved in several interactions that influence chromatin dynamics and gene expression. In the context of proliferative diabetic retinopathy (PDR), H2AC16 is identified as a core protein within a protein-protein interaction (PPI) network, suggesting its role in the pathophysiology of PDR. This network includes interactions with other histone proteins such as H2BC12 and H2AC13, indicating a potential collective role in oxidative stress-related pathways (Wang2024Unveiling).

H2AC16 is also implicated in the response to placebo and alcohol doses, where it is upregulated along with other histone genes. This upregulation affects pathways like systemic lupus erythematosus and neutrophil extracellular trap formation. The interactions between H2AC16 and other histone proteins, such as H2BC21 and H2BC5, are predicted to occur through activation, catalyzation, and binding of their protein products, suggesting a role in protein heterodimerization activity (Shetty2023Peripheral).

In cancer research, H2AC16 has been identified as a driver gene in certain cancer types, such as squamous cell carcinoma and adenocarcinoma. Its involvement in chromatin structure and function could affect histone-DNA interactions, nucleosome compaction, and histone post-translational modifications, although specific interactions with proteins or nucleic acids are not detailed (Ostroverkhova2023Leveraging).


## References


1. (Shetty2023Peripheral) Peripheral blood transcriptomic profiling indicates molecular mechanisms commonly regulated by binge-drinking and placebo-effects. This article has 0 citations.

[2. (Ostroverkhova2023Leveraging) Daria Ostroverkhova, Daniel Espiritu, Maria J. Aristizabal, and Anna R. Panchenko. Leveraging gene redundancy to find new histone drivers in cancer. Cancers, 15(13):3437, June 2023. URL: http://dx.doi.org/10.3390/cancers15133437, doi:10.3390/cancers15133437. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15133437)

[3. (Wang2024Unveiling) Jun Wang, Hongyan Sun, Lisha Mou, Ying Lu, Zijing Wu, Zuhui Pu, and Ming-ming Yang. Unveiling the molecular complexity of proliferative diabetic retinopathy through scrna-seq, alphafold 2, and machine learning. Frontiers in Endocrinology, May 2024. URL: http://dx.doi.org/10.3389/fendo.2024.1382896, doi:10.3389/fendo.2024.1382896. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2024.1382896)

[4. (Ragusa2023Contribution) Denise Ragusa and Paola Vagnarelli. Contribution of histone variants to aneuploidy: a cancer perspective. Frontiers in Genetics, November 2023. URL: http://dx.doi.org/10.3389/fgene.2023.1290903, doi:10.3389/fgene.2023.1290903. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2023.1290903)